Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial.

J Immunother Cancer · 2025 · PMC11950998 · PMID 40139834

Europe PMC DOI

hedged sentence

0.2520

closest p · 5.0× alpha

0.2520

boldest claim

The sentences

just failed to reach significancep=0.252not close (p > 0.1)

Similar correlations were observed after 3 months, but just failed to reach significance (PD-1 + CD8 + T cells (p=0.252) and PD-1 + CD4 + T cells (p=0.088)) ( online supplemental figure 2A,B ).

also in 279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.